Best deals to access real time data! |
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Amarin Corp. Plc ADS, Each Representing One Ordinary Share | AMRN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 2.76 | - | - | - | 2.76 | 02:05:03 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.81 | 2.83 | 0.02 | 0.71% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | - | - | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Other |
Amarin Corp. Plc ADS, Each Representing One Ordinary Share Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 817.92M | 296.35M | $ -67.87M | -0.25 | 0.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | 22.74k | 37.70% |
Amarin Corp. Plc ADS, Each Representing One Ordinary Share News
REDUCE-IT™ Trial Primary Results Accepted for Presentation at 2018 Scientific Sessions of American Heart Association GlobeNewswire Inc. • 
• Wed Sep 12, 2018 9:21 AM (7 days ago)
• Wed Sep 12, 2018 9:21 AM (7 days ago)Amarin’s REDUCE-IT™ Clinical Study Now Positioned to be Next Large Cardiovascular Outcomes Study to Report Results GlobeNewswire Inc. • • Sun Aug 26, 2018 11:00 AM (3 weeks ago)
• Sun Aug 26, 2018 11:00 AM (3 weeks ago)Real-World Data Supports Association Between Elevated Triglyceride Levels and Increased Peripheral Arterial Revascularization... GlobeNewswire Inc. • • Sat Aug 25, 2018 5:00 AM (4 weeks ago)
• Sat Aug 25, 2018 5:00 AM (4 weeks ago)Quarterly Report (10-q) Edgar (US Regulatory) • Wed Aug 01, 2018 6:38 AM (2 months ago)
Current Report Filing (8-k) Edgar (US Regulatory) • Wed Aug 01, 2018 6:34 AM (2 months ago)
Amarin Reports Second Quarter 2018 Financial Results and Provides Update on Operations GlobeNewswire Inc. • • Wed Aug 01, 2018 5:00 AM (2 months ago)
• Wed Aug 01, 2018 5:00 AM (2 months ago)Amarin Announces Approval for Vascepa® in United Arab Emirates GlobeNewswire Inc. • • Thu Jul 26, 2018 8:48 AM (2 months ago)
• Thu Jul 26, 2018 8:48 AM (2 months ago)|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMRN Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 3.21 | 3.22 | 2.6501 | 2.9214 | 3M | 5M | 4M | -0.45 | -14.02% |
| 1 Month | 2.84 | 3.32 | 2.6501 | 3.0485 | 2M | 7M | 4M | -0.08 | -2.82% |
| 3 Months | 2.83 | 3.32 | 2.35 | 2.9177 | 1M | 8M | 3M | -0.07 | -2.47% |
| 6 Months | 3.24 | 3.52 | 2.35 | 2.9724 | 863k | 8M | 3M | -0.48 | -14.81% |
| 1 Year | 3.2 | 4.6 | 2.35 | 3.2429 | 426k | 13M | 2M | -0.44 | -13.75% |
| 3 Years | 2.3 | 4.6 | 1.24 | 3.0370 | 287k | 17M | 2M | 0.46 | 20.00% |
| 5 Years | 6.48 | 7.39 | 0.78 | 2.5878 | 38k | 106M | 3M | -3.72 | -57.41% |
Amarin Corp. Plc ADS, Each Representing One Ordinary Share Description
| Amarin Corporation PLC is a biopharmaceutical company that commercializes and develops therapeutics to improve cardiovascular health. |
